337 related articles for article (PubMed ID: 22448595)
21. Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions.
Mendizábal VE; Adler-Graschinsky E
Br J Pharmacol; 2007 Jun; 151(4):427-40. PubMed ID: 17450170
[TBL] [Abstract][Full Text] [Related]
22. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
Cacabelos R
Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
[TBL] [Abstract][Full Text] [Related]
23. The expanding role of BDNF: a therapeutic target for Alzheimer's disease?
Fumagalli F; Racagni G; Riva MA
Pharmacogenomics J; 2006; 6(1):8-15. PubMed ID: 16314887
[TBL] [Abstract][Full Text] [Related]
24. [Current topics about mild cognitive impairment (MCI)].
Yamamoto Y
Seishin Shinkeigaku Zasshi; 2011; 113(6):584-92. PubMed ID: 21815470
[TBL] [Abstract][Full Text] [Related]
25. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
Townsend KP; Praticò D
FASEB J; 2005 Oct; 19(12):1592-601. PubMed ID: 16195368
[TBL] [Abstract][Full Text] [Related]
26. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.
Maczurek A; Hager K; Kenklies M; Sharman M; Martins R; Engel J; Carlson DA; Münch G
Adv Drug Deliv Rev; 2008; 60(13-14):1463-70. PubMed ID: 18655815
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic Potential of Cannabinoids in Psychosis.
Leweke FM; Mueller JK; Lange B; Rohleder C
Biol Psychiatry; 2016 Apr; 79(7):604-12. PubMed ID: 26852073
[TBL] [Abstract][Full Text] [Related]
28. Endocannabinoid overactivity and intestinal inflammation.
Di Marzo V; Izzo AA
Gut; 2006 Oct; 55(10):1373-6. PubMed ID: 16966693
[TBL] [Abstract][Full Text] [Related]
29. Alzheimer's disease, aging, and cannabidiol treatment: a promising path to promote brain health and delay aging.
Liu Y
Mol Biol Rep; 2024 Jan; 51(1):121. PubMed ID: 38227160
[TBL] [Abstract][Full Text] [Related]
30. Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.
Fraguas-Sánchez AI; Fernández-Carballido A; Torres-Suárez AI
Expert Opin Investig Drugs; 2016 Nov; 25(11):1311-1323. PubMed ID: 27633508
[TBL] [Abstract][Full Text] [Related]
31. Endocannabinoid System in Neurological Disorders.
Ranieri R; Laezza C; Bifulco M; Marasco D; Malfitano AM
Recent Pat CNS Drug Discov; 2016; 10(2):90-112. PubMed ID: 27364363
[TBL] [Abstract][Full Text] [Related]
32. Inflammation and aging: can endocannabinoids help?
Marchalant Y; Brothers HM; Wenk GL
Biomed Pharmacother; 2008; 62(4):212-7. PubMed ID: 18400455
[TBL] [Abstract][Full Text] [Related]
33. Targeting ubiquilin-1 in Alzheimer's disease.
Takalo M; Haapasalo A; Natunen T; Viswanathan J; Kurkinen KM; Tanzi RE; Soininen H; Hiltunen M
Expert Opin Ther Targets; 2013 Jul; 17(7):795-810. PubMed ID: 23600477
[TBL] [Abstract][Full Text] [Related]
34. New and emerging treatments for Alzheimer's disease.
Corbett A; Smith J; Ballard C
Expert Rev Neurother; 2012 May; 12(5):535-43. PubMed ID: 22550982
[TBL] [Abstract][Full Text] [Related]
35. Endocannabinoid System Biomarkers in Alzheimer's Disease.
Ferreira PCL; Bellaver B; Povala G; Brum WS; Tissot C; Badji A; Sloan ME; Benedet AL; Rosa-Neto P; Ashton NJ; Pascoal TA; Leuzy A; Zimmer ER
Cannabis Cannabinoid Res; 2023 Feb; 8(1):77-91. PubMed ID: 36394442
[No Abstract] [Full Text] [Related]
36. Antibody-based therapy in Alzheimer's disease.
Pul R; Dodel R; Stangel M
Expert Opin Biol Ther; 2011 Mar; 11(3):343-57. PubMed ID: 21261567
[TBL] [Abstract][Full Text] [Related]
37. The endocannabinoid system: a general view and latest additions.
De Petrocellis L; Cascio MG; Di Marzo V
Br J Pharmacol; 2004 Mar; 141(5):765-74. PubMed ID: 14744801
[TBL] [Abstract][Full Text] [Related]
38. Galantamine for Alzheimer's disease.
Prvulovic D; Hampel H; Pantel J
Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):345-54. PubMed ID: 20113148
[TBL] [Abstract][Full Text] [Related]
39. Endocannabinoid signalling in Alzheimer's disease.
Maroof N; Pardon MC; Kendall DA
Biochem Soc Trans; 2013 Dec; 41(6):1583-7. PubMed ID: 24256258
[TBL] [Abstract][Full Text] [Related]
40. Can herbs provide a new generation of drugs for treating Alzheimer's disease?
Anekonda TS; Reddy PH
Brain Res Brain Res Rev; 2005 Dec; 50(2):361-76. PubMed ID: 16263176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
